Vioxx Users vs. Merck & Co.

Merck & Co., Inc. recently announced a voluntary withdrawal of Vioxx (rofecoxib) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx. Vioxx is a prescription drug that was approved by FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms. Vioxx was later approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children.

Merck informed the FDA that a recent study showed an increased risk of heart attack and stroke in patients on Vioxx, particularly those who had been taking the drug for longer than 18 months. In the study, patients taking higher doses of Vioxx (more than 25 mg daily) had triple the risk of heart problems, including heart attacks and sudden cardiac death. Based on this new safety information, Merck and FDA officials met on September 28, 2004 and during that meeting the FDA was informed that Merck was voluntarily withdrawing Vioxx from the market place. Individuals who are currently taking Vioxx have been urged to contact their physician for guidance regarding discontinuation and alternative therapies.

If you or a loved one has suffered heart attack, stroke or serious side effect from Vioxx, or if a loved one has died while taking Vioxx, you may be entitled to monetary compensation. For a free review of your claim, please complete the Vioxx Information Form. Upon submission, your Vioxx Information Form will be evaluated by a member of our staff. That lawyer will personally evaluate your case, and may contact you to further discuss your situation. Please be advised that by submitting a Vioxx Information Form, we are not agreeing to undertake representation of you in connection with a potential claim for damages as a result of your Vioxx use. The Vioxx Information Form is being supplied solely to allow us to make an initial determination.

Please call Terri Lightner toll free at 1-877-621-1228 if you have any questions.

Click here to prepare online a confidential questionnaire. Submission of your information will enable us to make a preliminary determination of a potential claim without any cost to you.